Global Life Science Ventures — Investing in the life sciences

Global Life Science Ventures (GLSV) was a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund also invested in selected later stage companies, including buy-outs. For this purpose, GLSV provided finance, advice and access to expertise and networks. The group advised and managed funds totaling more than € 200 million. With offices in Germany and Switzerland, GLSV acted as one team with a global perspective.
The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation.

Currenty, no new investments are being sought.

Text size

Imprint

Global Life Science Ventures GmbH
Tal 26
D - 80331 München
Germany
Phone +49 (0)89 - 288 151-0
Fax +49 (0)89 - 288 151-30
Email: mailbox@glsv-vc.com

Geschäftsführer: Dr. Hans A. Küpper and Hanns-Peter Wiese

Commercial Register: Amtsgericht München HBR 132978
VAT reg. no.: DE 224668351

Global Life Science Ventures AG
Postplatz 1, P.O. Box 626
CH - 6301 Zug
Switzerland
Phone +41 (0)41 - 727 19 40
Fax +41 (0)41 -727 19 45
Email: mailbox@glsv-vc.com

Geschäftsführer: Dr. Peter H. Reinisch

Commercial Register: CH-170.3.024.470-9
VAT reg. no.: 518231

 

 

made by: Genius GmbH & mcw Mediahouse